Protocol for a cluster randomised controlled trial of secondary distribution of hepatitis C self-testing within the context of a house-to-house hepatitis C micro-elimination programme in Karachi, Pakistan

Table 1 Study timeline

	Enrolment	Follow-up for all participants	Follow-up for HCV antibody-positive participants
Procedure	Day 1	Months 1–2	Months 1–8
Inclusion and exclusion criteria	X
Informed consent obtained	X
HCV antibody testing (either HCV self-test left with the household or participants in the control group attend Memon Goth Hospital)	X	X
Collection of test results and survey of perceptions of the testing process		X
Referral of HCV antibody-positive individuals for confirmatory testing and linkage to care		X	X
Linking of data for the RDT (control group) and RNA test and treatment initiation (as applicable for the intervention and control groups)		X	X
Adverse event (AE)/serious adverse event (SAE) review	X	X	X
Cost data collection and analysis	X	X	X

ISSN: 1471-2458